Predicting the occurrence of multidrug-resistant organism colonization or infection in ICU patients: development and validation of a novel multivariate prediction model
- PMID: 32430043
- PMCID: PMC7236142
- DOI: 10.1186/s13756-020-00726-5
Predicting the occurrence of multidrug-resistant organism colonization or infection in ICU patients: development and validation of a novel multivariate prediction model
Abstract
Background: Multidrug-resistant organisms (MDROs) have emerged as an important cause of poor prognoses of patients in the intensive care unit (ICU). This study aimed to establish an easy-to-use nomogram for predicting the occurrence of MDRO colonization or infection in ICU patients.
Methods: In this study, we developed a nomogram based on predictors in patients admitted to the ICU in the First Affiliated Hospital of Xiamen University from 2016 to 2018 using univariate and multivariate logistic regression analysis. We externally validated this nomogram in patients from another hospital over a similar period, and assessed its performance by calculating the area under the receiver operating characteristic (ROC) curve (AUC) and performing a decision curve analysis.
Results: 331 patients in the primary cohort and 181 patients in the validation cohort were included in the statistical analysis. Independent factors derived from the primary cohort to predict MDRO colonization or infection were male sex, higher C-reactive protein (CRP) levels and higher Pitt bacteremia scores (Pitt scores), which were all assembled in the nomogram. The nomogram yielded good discrimination with an AUC of 0.77 (95% CI 0.70-0.84), and the range of threshold probabilities of decision curves was approximately 30-95%.
Conclusion: This easy-to-use nomogram is potentially useful for predicting the occurrence of MDRO colonization or infection in ICU patients.
Keywords: CRP; Colonization; ICU; Infection; Multidrug-resistant organisms; Pitt score.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures



References
-
- Rice LB. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no eskape. Infect Dis. 2008;197(8):1079–1081. - PubMed
-
- Albiger B, Glasner C, Struelens MJ, Grundmann H, Monnet DL. Carbapenemase-producing Enterobacteriaceae in Europe: assessment by national experts from 38 countries. Euro Surveill. 2015;20(45):1–18. - PubMed
-
- Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard deinitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–281. - PubMed
-
- Organization W H Antimicrobial resistance: global report on surveillance. Australasian Med J. 2014;7(4):237.
-
- Ministry of Health PRC Technical guidelines for the prevention and control of nosocomial infection with multidrug resistant bacteria (trial) Chin Crit Care Med. 2011;13(2):108–109.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous